Outcomes of Ventral Hernia Repair with Concomitant Cholecystectomy to Chole Or Not to Chole

Outcomes of Ventral Hernia Repair with Concomitant Cholecystectomy to Chole Or Not to Chole

Outcomes of Ventral Hernia Repair with Concomitant Cholecystectomy To chole or not to chole Charlotte M. Horne, MD Fellow Cleveland Clinic Center for Abdominal Core Health 12.12.2019 Disclosures • None Case Presentation • 58 y/o F presenting with a painful recurrent incisional hernia • PMHx: Hypothyroidism • PSHx: TAH, VHR c/b mesh infection, recurrent hernia repair with Strattice underlay Case Presentation To chole or not to chole ? • Surgical history What factors • Operative approach • Size of hernia would guide • Gallstone size your decision? • Number of gallstones • Patient comorbidities Background • Decision to remove gallbladder is complex • Many factors may guide operative decision making • Lack of data Background Complex AWR results in - Larger pieces of mesh being used - Increased technical difficulty of future cholecystectomy Background Defer cholecystectomy ? Concomitant cholecystectomy Pros Cons • Avoids re-operative • Upstage wound class cholecystectomy • ? Increase risk of • Avoids incisions in mesh infectious mesh • Decreased health care complication utilization • Patient may never need cholecystectomy • “Gallbladders can only make you look bad” Aim To determine if concomitant cholecystectomy increases post-operative wound morbidity Methods: AHSQC 2013-2019 Excluded: Open Abdominal Wall • Concomitant cases • Intra-op complication Reconstruction +/- CCY 6440 Open AWR 130 Open AWR + CCY Clean Class 1 Methods: • Retrospective analysis • Primary outcome: 30 day wound morbidity • SSI: superficial, deep or organ space infection • SSOPI: opening of wound, debridement, any mesh removal AWR AWR + CCY P-value N = 6440 N = 130 Results: ASA, n (%) 0.01 Demographics • 1 248 (4%) 2 (2%) • 2 2468 (38%) 24 (18%) • 3 3554 (55%) 99 (76%) • 4 165 (3%) 5 (4%) Gender, n (%) 0.357 • Male 3086 (48%) 57 (44%) • Female 3354 (52%) 73 (56%) BMI (Q1, median, Q3) 28 31 36 28 33 38 0.012 Immunosuppressants, n (%) 428 (7%) 7 (5%) 0.551 Smoking within 1 year, n (%) 750 (12%) 16 (12%) 0.844 Diabetes Mellitus, n (%) 1314 (21%) 37 (29%) 0.028 COPD, n (%) 456 (7%) 20 (15%) <0.001 History of Abd Wall SSI, n (%) 1150 (18%) 34 (26%) 0.017 Results: AWR AWR + P-value Hernia Characteristics N = CCY 6440 N = 130 Recurrent or Primary, n 0.018 (%) • Primary 3691 61 (47%) (57%) • Recurrent 2749 69 (53%) (43%) Hernia Width cm (Q1, 5 8 13 7 12 15 <0.001 median, Q3) Operative Details n (%) AWR AWR + CCY P-value N = 6440 N = 130 Operative Time (minutes) <0.001 0 – 59 703 (11%) 2 (2%) 60 – 119 1482 (23%) 8 (6%) 120 – 179 1803 (28%) 33 (25%) 180 – 239 1191 (18%) 32 (25%) 240+ 1261 (20%) 55 (42%) Fascial Closure, n (%) 6145 (95%) 123 (95%) 0.659 Myofascial Release, n (%) 4221 (66%) 105 (81%) <0.001 Mesh Location, n (%) 0.867 Intraperitoneal 706 (13%) 8 (7%) Preperitoneal 2272 (41%) 55 (48%) Retromuscular 3988 (71%) 99 (86%) >1 Location 1356 (24%) 47 (41%) AWR AWR + CCY P- Operative Details, n (%) N = 6440 N = 130 value Mesh Type Permanent Synthetic 6076 (94%) 106 (82%) <0.001 Resorbable Synthetic 196 (3%) 7 (5%) Biologic 151 (2%) 16 (12%) Wound Classification Clean (Class 1) 6440 (100%) 37 (29%) <0.001 Clean Contaminated (Class 2) Excluded 82 (63%) Contaminated (Class 3) Excluded 8 (6%) Dirty Infected (Class 4) Excluded 3 (2%) Results: 30 Day Outcomes AWR AWR + CCY P-value N = 6440 N = 130 SSI, n (%) 219 (4%) 2 (2%) 0.250 SSOPI, n (%) 348 (6%) 7 (6%) 0.983 Re-operation, n (%) 101 (2%) 1 (1%) 0.473 Death n (%) 12 (<1%) 2 (2%) 0.020 PE, n (%) 44 (1%) 0 (0%) 0.347 DVT, n (%) 22 (<1%) 2 (2%) 0.024 Renal Insufficiency, n (%) 20 (<1%) 0 (0%) 0.527 Resp Failure with Intubation 46 (1%) 3 (3%) 0.035 Post-op Bleeding Transfusion 44 (1%) 0 (0%) 0.347 Factors associated with SSI • Female gender • Recurrent incisional hernia • Hx of ab wall SSI Factors associated with SSOPI • Diabetes • ASA Class • Hx of ab wall SSI • Subcutaneous flaps raised Conclusions • Concomitant cholecystectomy in AWR was not shown to increase wound morbidity • Patient factors predictive or SSI/SSOPI - DM - ASA Class - Gender - Previous history of ab wall SSI Limitations • Unclear indication for cholecystectomy • Database limitations • Groups were not similar - Larger, recurrent hernias - Increased comorbidities Summary • Cholecystectomy can be offered at AWR • Ideal candidates for concomitant cholecystectomy still undefined • Consideration of patient factors & hernia complexity may help guide decision making hernia.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    24 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us